Chronic obstructive pulmonary disease (COPD) is one of the four major chronic diseases in China and the third largest death rate in China, with an average of about 2 per minuteFive people died of COPD. There are nearly 100 million patients with COPD in China, and the awareness rate of patients is very low (about 09%), and the rate of pulmonary function tests over 40 years old is only 45%, so the early diagnosis and detection rate is very low, and many patients are already very sick when they visit the clinic, losing their ability to work and even being unable to take care of themselves. The annual cost of COPD** per patient is as high as more than 20,000 yuan, which has become a financial burden for some families. Therefore, the state has issued a series of long-term plans such as "Healthy China", hoping to improve the diagnosis rate of COPD and reduce the mortality rate of COPD.
The diagnosis and advancement of COPD is the breakthrough point of COPD prevention and controlAcademician Zhong Nanshan and other experts appealed. Based on numerous studies, we know that the sooner COPD** is performed, the greater the degree of recovery in lung function.
He was the first to join the COMPASS researcher team of Academician Zhong Nanshan.
In 2019, the Department of Respiratory and Critical Care Medicine of Zhuhai People's Hospital, which continues to pay attention to COPD**, took the lead in joining the COMPASS investigator team of Academician Zhong Nanshan to evaluate the patient's lung function, lung CT, health status score, frequency of acute exacerbations, and changes in daily activity to evaluate the number of COPD research subjects in 2The progression of the disease in the past 5 years will further understand the occurrence and development characteristics of COPD in China, so as to contribute to the management and development of COPD.
In the past three years, the COMPASS research team of the Department of Respiratory and Critical Care Medicine has successfully enrolled 98 subjects and conducted a two-and-a-half-year follow-up observation study, while providing close guidance on the daily management and ** of COPD patients.
So, what is the result?
Pennants are also a kind of proof of the patient**.
Recently, the Compass research team from the Department of Respiratory and Critical Care Medicine received 7 pennants from patients"As a team dedicated to Compass research, we have always been patient-centric and committed to providing the highest quality medical care and care. These pennants are not only the recognition and encouragement of our patients, but also the affirmation of our selfless dedication. "Health care workers can't put into words how happy they feel.
In the past two and a half years, the compass research team of the Department of Respiratory and Critical Care Medicine of Zhuhai People's Hospital has established a deep trust and close cooperative relationship with each patient, and has gone through every stage of the journey together, sharing joys and challenges. The pennant not only represents the recognition of the team, but also a proof of the patients.
It can screen for early-stage lung cancer, tuberculosis and other diseases.
In terms of patient screening, the COMPASS research team of the Department of Respiratory and Critical Care Medicine of Zhuhai People's Hospital has also made a breakthrough. It not only successfully screened patients with different degrees of COPD, but also found some patients with early lung cancer, tuberculosis and other diseases, which won the opportunity for these patients to get the right one at an early stage and reduced the burden of patients.
Patient's close doctor and**.
However, the team's work didn't stop there. They are well aware that patients may have many questions and confusion when facing the disease, so they play the role of personal doctors and ** to establish a close connection with patients. Through multiple follow-up visits, communicate and communicate with patients, answer various disease-related questions, and provide professional advice and guidance.
This personal doctor and ** model can not only make patients feel cared for and supported, but also help them better understand and manage their own diseases.
We believe that through timely follow-up and guidance, patients can better grasp their disease situation, take the right measures, and actively face the disease and improve their quality of life. ”
We are grateful to all the patients who participated in this study, their trust and support are the motivation for our continuous efforts. ”
The team also said that in the future, it will continue to work hard to continue to explore and innovate in the management of chronic respiratory diseases, provide better medical services and care for patients, and help more patients detect and manage diseases as soon as possible, so that they can enjoy a healthier and better life.